Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry|February 1, 2003
Oligodeoxynucleotide-modified capillary for electrophoretic separation of single-stranded DNAs with a single-base differenceTakahisa Anada, Masako Ogawa, Hisashi Yokomizo, et al.
Frontiers in Endocrinology|December 19, 2022
Combined treatment by burosumab and a calcimimetic can ameliorate hypophosphatemia due to excessive actions of FGF23 and PTH in adult XLH with tertiary hyperparathyroidism: A case reportYuichi Takashi, Kyoko Toyokawa, Naoki Oda, et al.
Diabetology International|April 1, 2025
Anti-GAD antibody-negative, anti-IA2 antibody-positive slowly progressive insulin-dependent diabetes mellitus and Graves' disease preceded by childhood-onset minimal change nephrotic syndrome: a case reportYoshimi Kodama, Taijiro Okabe, Shuji Sasaki, et al.
Journal of Diabetes Investigation|May 5, 2021
Bilirubin is inversely related to diabetic peripheral neuropathy assessed by sural nerve conduction studyKentaro Abe, Yasutaka Maeda, Chitose Matsuzaki, et al.
Metabolism: Clinical and Experimental|May 5, 2012
GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidasesHari Hendarto, Toyoshi Inoguchi, Yasutaka Maeda, et al.
Atherosclerosis|March 31, 2015
GLP-1 analog liraglutide protects against cardiac steatosis, oxidative stress and apoptosis in streptozotocin-induced diabetic ratsTomoaki Inoue, Toyoshi Inoguchi, Noriyuki Sonoda, et al.
Diabetology International|April 1, 2025
Relationship of dietary intake and eating behaviors with glycemic control and body weight under long-term treatment with dapagliflozin: an exploratory prospective studyHisashi Yokomizo, Daiji Kawanami, Noriyuki Sonoda, et al.
Circulation Research|September 1, 2017
Regulation of Macrophage Apoptosis and Atherosclerosis by Lipid-Induced PKCδ Isoform ActivationQian Li, Kyoungmin Park, Yu Xia, et al.
Journal of Diabetes Investigation|May 7, 2025
Liver function effects of SGLT2 inhibitor and GLP-1 receptor agonist combination treatment in patients with type 2 diabetes (post hoc analysis of RECAP study)Daisuke Tsuriya, Kazuo Kobayashi, Kei Takeshita, et al.
The Tokai Journal of Experimental and Clinical Medicine|March 19, 2025
Influence of Combination Therapy with Dulaglutide or Liraglutide and SGLT2 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Post-hoc Analysis of the RECAP StudyYoshimi Muta, Kazuo Kobayashi, Masao Toyoda, et al.
Pageof 3